share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Arbuckle Stuart A

福泰制药 | 4：持股变动声明-高管 Arbuckle Stuart A

SEC announcement ·  02/27 16:45
Moomoo AI 已提取核心信息
Stuart A Arbuckle, EVP and COO of Vertex Pharmaceuticals Inc. (VRTX), completed the sale of 9,748 shares of common stock in two separate transactions. On February 23, 2024, Arbuckle disposed of 4,714 shares at a price of $431.79 per share. Following this transaction, he sold an additional 5,034 shares on February 26, 2024, at a price of $425.7 each. After these transactions, Arbuckle's direct holdings in Vertex Pharmaceuticals totaled 49,691 shares. The total market value of the disposed shares amounted to approximately $4,178,431.86. Additionally, Arbuckle holds 140 shares indirectly through a 401(k) plan.
Stuart A Arbuckle, EVP and COO of Vertex Pharmaceuticals Inc. (VRTX), completed the sale of 9,748 shares of common stock in two separate transactions. On February 23, 2024, Arbuckle disposed of 4,714 shares at a price of $431.79 per share. Following this transaction, he sold an additional 5,034 shares on February 26, 2024, at a price of $425.7 each. After these transactions, Arbuckle's direct holdings in Vertex Pharmaceuticals totaled 49,691 shares. The total market value of the disposed shares amounted to approximately $4,178,431.86. Additionally, Arbuckle holds 140 shares indirectly through a 401(k) plan.
Vertex Pharmicals Inc.（VRTX）执行副总裁兼首席运营官斯图尔特·阿巴克尔在两笔单独的交易中完成了9,748股普通股的出售。2024年2月23日，阿巴克尔以每股431.79美元的价格出售了4,714股股票。在这笔交易之后，他于2024年2月26日又以每股425.7美元的价格出售了5,034股股票。在这些交易之后，Arbuckle在Vertex Pharmicals的直接持股总额为49,691股。已处置股份的总市值约为4,178,431.86美元。此外，阿巴克尔通过401（k）计划间接持有140股股票。
Vertex Pharmicals Inc.（VRTX）执行副总裁兼首席运营官斯图尔特·阿巴克尔在两笔单独的交易中完成了9,748股普通股的出售。2024年2月23日，阿巴克尔以每股431.79美元的价格出售了4,714股股票。在这笔交易之后，他于2024年2月26日又以每股425.7美元的价格出售了5,034股股票。在这些交易之后，Arbuckle在Vertex Pharmicals的直接持股总额为49,691股。已处置股份的总市值约为4,178,431.86美元。此外，阿巴克尔通过401（k）计划间接持有140股股票。
有用
没用

该公告为独立文件：

独立文件1

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息